VAR - Varian Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
130.88
-1.20 (-0.91%)
At close: 4:03PM EDT
Stock chart is not supported by your current browser
Previous Close132.08
Open132.35
Bid130.90 x 800
Ask130.93 x 1100
Day's Range130.61 - 132.35
52 Week Range101.42 - 142.50
Volume518,368
Avg. Volume567,357
Market Cap11.903B
Beta (3Y Monthly)0.95
PE Ratio (TTM)31.80
EPS (TTM)4.12
Earnings DateJul 23, 2019 - Jul 29, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1998-12-02
1y Target Est148.57
Trade prices are not sourced from all markets
  • PR Newswire4 days ago

    Varian to Deliver Six Technical Presentations at ICCR

    PALO ALTO, Calif. , June 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be delivering presentations focused on artificial intelligence (AI),   federated data sources and clinical decision ...

  • PR Newswire5 days ago

    Proton Clinical Research Center of the Shandong Cancer Hospital First APAC Member of FlashForward Consortium

    PALO ALTO, Calif. , June 12, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the Proton Clinical Research Center of the Shandong Cancer Hospital, is the first center in Asia Pacific to join the ...

  • PR Newswire5 days ago

    Varian Medical Systems Presents Latest Innovations in Radiotherapy at DEGRO 25

    MÜNSTER, Germany, June 12, 2019 /PRNewswire/ -- Varian (VAR) will showcase and discuss its latest innovations in radiotherapy at the DEGRO 25 (German Society for Radio Oncology) meeting in Münster, Germany, June 13-16. At the core of the company's DEGRO 25 meeting activities is its Halcyon™ radiotherapy system, which has gone live at seven treatment centers in Germany. During a lunch symposium on June 14 (time and location: see below), Dr. Johannes Gollrad from Charité Universitätsmedizin Berlin as well as Prof. Dr. Florian Würschmidt and Dr. Matthias Kretschmer from Radiologische Allianz Hamburg will discuss their experience with Halcyon.

  • Varian Medical Buys Endocare & Alicon to Boost Cancer Care
    Zacks6 days ago

    Varian Medical Buys Endocare & Alicon to Boost Cancer Care

    Varian Medical (VAR) expects the buyouts to prove accretive to bottom line in fiscal 2020.

  • PR Newswire6 days ago

    Varian to Demonstrate New Bravos Afterloader System at ABS 2019

    PALO ALTO, Calif. , June 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced it will be showcasing its Bravos ™ afterloader system for High Dose Rate (HDR) brachytherapy treatments and other advanced ...

  • PR Newswire7 days ago

    Varian Expands Cancer Care Solutions Portfolio with Interventional Oncology Acquisitions

    PALO ALTO, Calif., June 10, 2019 /PRNewswire/ -- Varian (VAR) today announced it has acquired Austin, Texas-based Endocare and Hangzhou, China-based, Alicon, to expand its portfolio of multidisciplinary integrated cancer care solutions.

  • Hedge Funds Have Never Been This Bullish On Varian Medical Systems, Inc. (VAR)
    Insider Monkey7 days ago

    Hedge Funds Have Never Been This Bullish On Varian Medical Systems, Inc. (VAR)

    It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. Since stock returns aren't usually symmetrically distributed and index […]

  • Markit7 days ago

    See what the IHS Markit Score report has to say about Varian Medical Systems Inc.

    Varian Medical Systems Inc NYSE:VARView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for VAR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting VAR. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding VAR totaled $4.98 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • PR Newswire7 days ago

    Herlev University Hospital Treats First Patient in Denmark on Varian Halcyon System

    PALO ALTO, Calif. and HERLEV, Denmark, June 10, 2019 /PRNewswire/ -- Varian (VAR) today announced Herlev University Hospital near Copenhagen, Denmark is Scandinavia's first facility to utilize the Halcyon™ system. The first patient treated on the system was a 42-year-old female undergoing treatment for anal cancer.

  • PR Newswire10 days ago

    Varian-equipped New York Proton Therapy Center Opens with Ribbon Cutting Event

    PALO ALTO, Calif. , June 7, 2019 /PRNewswire/ -- Providing access to proton therapy treatment for cancer patients in the tri-state area, the New York Proton Center (NYPC) held a ribbon cutting event yesterday ...

  • Varian (VAR) Set to Exhibit ProBeam Proton Therapy System
    Zacks10 days ago

    Varian (VAR) Set to Exhibit ProBeam Proton Therapy System

    Varian's (VAR) ProBeam exhibition is in sync with its strategy to expand reach within the cancer care market.

  • PR Newswire10 days ago

    Varian to Host FlashForward Consortium Meeting at PTCOG58

    PALO ALTO, Calif. , June 7, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be hosting its second FlashForward ™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58 th annual Particle ...

  • PR Newswire11 days ago

    Varian Showcasing Latest Proton Therapy Systems and Technology at PTCOG Conference 58

    PALO ALTO, Calif. , June 6, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced it will be showcasing its new ProBeam ®  360° proton therapy system*, June 12 th -15 th in Manchester, United Kingdom at the ...

  • Why Varian Medical Systems, Inc. (NYSE:VAR) Is A Financially Healthy Company
    Simply Wall St.12 days ago

    Why Varian Medical Systems, Inc. (NYSE:VAR) Is A Financially Healthy Company

    With a market capitalization of US$12b, Varian Medical Systems, Inc. (NYSE:VAR) is a large-cap stock, which is...

  • AngioDynamics Divests NAMIC Portfolio to Medline Industries
    Zacks12 days ago

    AngioDynamics Divests NAMIC Portfolio to Medline Industries

    The NAMIC fluid management portfolio sale clears all of AngioDynamics' (ANGO) outstanding debt.

  • PR Newswire19 days ago

    Varian to Showcase Software Solutions at ASCO Annual Meeting

    PALO ALTO, Calif. , May 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing its Noona ®  patient management system and its 360 Oncology™ care management platform, May 31-June ...

  • PR Newswire20 days ago

    Varian Eclipse User Takes Top Spot in 2019 TROG Pancreas Treatment Plan Study

    PALO ALTO, Calif. , May 28, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a physicist using Varian's Eclipse ™ treatment planning system achieved the top overall score in the TROG 2019 Stereotactic ...

  • Here's Why You Should Hold Varian Medical (VAR) Stock Now
    Zacks21 days ago

    Here's Why You Should Hold Varian Medical (VAR) Stock Now

    Varian Medical (VAR) raises revenue guidance for 2019 encourages.

  • American City Business Journals24 days ago

    Roundup for this week's deals and dollars | May 24, 2019

    Here's a look at some of the deals and dollars involving North Texas companies and firms this week.

  • Why Is Varian (VAR) Down 4.9% Since Last Earnings Report?
    Zacks24 days ago

    Why Is Varian (VAR) Down 4.9% Since Last Earnings Report?

    Varian (VAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Thomson Reuters StreetEvents26 days ago

    Edited Transcript of VAR earnings conference call or presentation 24-Apr-19 8:30pm GMT

    Q2 2019 Varian Medical Systems Inc Earnings Call

  • Stock Market News For May 21, 2019
    Zacks27 days ago

    Stock Market News For May 21, 2019

    Wall Street closed in the red on Monday as blacklisting of the Chinese tech behemoth Huawei by the U.S. government hit technology stocks.

  • Varian Medical's CTSI Buyout to Boost Oncology Services Unit
    Zacks27 days ago

    Varian Medical's CTSI Buyout to Boost Oncology Services Unit

    The CTSI buyout is expected to prove accretive to Varian Medical's (VAR) adjusted earnings per share during fiscal 2021.

  • Benzinga27 days ago

    The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 20) Kaleido Biosciences Inc (NASDAQ: KLDO ) Down In The ...

  • PR Newswire28 days ago

    Varian Announces Definitive Agreement to Acquire Cancer Treatment Services International

    PALO ALTO, Calif., May 20, 2019 /PRNewswire/ -- Taking an important step to accelerate innovation of new multidisciplinary solutions to address the growing global cancer burden, Varian Medical Systems (VAR) today announced it has entered into a definitive agreement to acquire Cancer Treatment Services International (CTSI) for $283 million. Privately held, CTSI operates the American Oncology Institute in Hyderabad and 10 multidisciplinary—radiation, medical and surgical oncology— cancer centers across the Indian subcontinent as well as a U.S.-based Oncology Solutions division that provides cancer care professional services to healthcare providers worldwide.